Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

FDA Approves Gene Therapy for Severe Leukocyte Adhesion Deficiency-I, a Rare Immune Disorder

The U.S. Food and Drug Administration granted accelerated approval for a gene therapy for severe leukocyte adhesion deficiency-I -- a genetic condition characterized by recurrent infections and, often, early death.

March 27, 2026


March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026

March 20 2026

March 19 2026

March 18 2026

March 17 2026

March 16 2026

March 15 2026

March 14 2026